Search

everythinglearnresearchcommunity

for

Search:↓

Older males had higher death rates, and Latin Americans were more often in the ICU during the COVID-19 outbreak in a Spanish hospital.

PROTACs show promise for cancer treatment, but designing them effectively is challenging.

No link found between aromatase gene and female hair loss.

Protease Nexin-1 is found in human hair growth cells and is affected by male hormones.

5α reductase type 2 enzyme mutation and oxidative stress may increase androgenetic alopecia risk in Egyptians.

Genetic mutations can affect female sexual development, requiring personalized medical care.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

Finasteride can have lasting negative effects on brain function and behavior by disrupting neurosteroid production.

Androgens significantly affect female hair loss, and hormonal treatments may help.

Chrousos Syndrome is caused by mutations that make the body less sensitive to glucocorticoids, leading to various symptoms and requiring high-dose treatment.

Possible link between androgens and COVID-19 severity; more research needed.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

There's no significant genetic link between male pattern baldness and COVID-19.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

Blocking the FGF5 gene in sheep leads to more fine wool and active hair follicles due to changes in certain cell signaling pathways.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

A single amino acid change in the vitamin D receptor can disrupt its function and lead to hair loss.

A protein called ectodysplasin-A2 increases a hair growth inhibitor in balding cells, which could be a target for hair loss treatment.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Alopecia patients have less GPER-1, which might affect hair loss.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

Different women's hair and skin glands respond to hormones in varied ways, which can cause unwanted hair growth even with normal hormone levels, and more research is needed to treat this effectively.

Androgens like testosterone affect hair growth and oil production differently across body parts and individuals.

Hair loss in women not always linked to increased oil production; other factors may be involved.

Treatment during development affects hormone balance and sexual behavior in male rats.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Melatonin receptors in hair follicles help regulate hair growth and could treat hair loss.

Finasteride helps treat skin issues like acne and baldness by blocking testosterone conversion.